The patient of Chinese rheumatism and arthritis and strong straightforward backbone inflammation diagnoses the delay phenomenon more

The patient of Chinese rheumatism and arthritis and strong straightforward backbone inflammation diagnoses the delay phenomenon more
Cable of June 14 of Beijing of China News Service (reporter Zeng LiMing) Nearly there are 9 millionth rheumatoid arthritis and strong straightforward backbone inflammation patient at present in China Mainland, the intersection of diagnosis and delay that cause because of lacking of understanding to rheumatism disease knowledge and treat, want to be phenomenon to be very much common. This China cure the intersection of SCTE and the intersection of rheumatism and immune the intersection of branch and president, the intersection of BJ Union Hospital and the intersection of rheumatism and immune the intersection of head of the department and one, doctor of training, present information that a professor reveals today in spring with respect. The rheumatism large-scale public welfare project of disease of care which he holds here " Feel grateful and take action " Claim at the unveiling ceremony. A lot of patients develop with the condition, the joint function is damaged gradually, cause workforces to lose, cause daily life to be unable to take care of oneself finally. About 50% of the rheumatoid arthritis patients develop into the intermediate function in 2 years after diagnosis and lose, the function at various degrees will happen and lose to 60% of the strong straightforward backbone inflammation patients, a lot of patients lose courage and confidence of life. Professor Zhang points out, with the use of the biological medicine, already there is breakthrough progress in the treatment of rheumatism disease, the correct treatment, can make rheumatoid and arthritis and strong straightforward backbone inflammation patient work, study even participate in sports like normal people in time. The control over rheumatism disease of developed country has already been expanded since drug therapy to the support and care of the society of the family at present. In order to popularize rheumatism disease knowledge, arouse the care to the patient of rheumatism of the whole society, China cure the intersection of SCTE and the intersection of rheumatism and immune branch and the intersection of Pfizer and China, doctor of training, start care about rheumatism nature full-length public welfare project of disease jointly " Feel grateful and take action " . The activity, through collecting a rheumatism patient and treating the experience to realize and exchange in the whole country in the network platform, encourage more patients to overcome disease. (End)

|